We’re missing too many patients at risk for esophageal cancer. ~40% don’t report reflux symptoms—yet current screening for Barrett’s esophagus depends on it. Drs. John Inadomi of @UofUHealth and Perica Davitkov of @CWRUSOM previewed how a new risk-based approach + minimally invasive tools could expand access and save lives at #DDW2026. #CancerScreening
Future GI trainees 📣📢
With the application cycle upon us, let us give you an inside look at the Case Western/University Hospital Gastroenterology and Hepatology ACGME training program
Check out our program with this video:
https://t.co/skXIcRMd70
NEW GUIDELINE‼️🎈📢
An absolute honor to work with the panel, technical review experts & methodologists and @AmerGastroAssn on the Clinical Practice Guidelines on #Intragastric_Balloons in the Management of #Obesity
Tweetorial 1/23: let’s take a deeper dive👇
23/ end
THANK YOU for following this tweetorial on the topic of @AmerGastroAssn Clinical Practice Guidelines on Intragastric Balloons 🎈 in the Management of #Obesity
21/
Check out the final manuscripts
🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥
Technical review: https://t.co/m2KB0zdDl0
Guideline: https://t.co/qFchAH6Goz
Spotlight: https://t.co/EAR52dObv2
Thank you to @AmerGastroAssn@AGA_Gastro 👏🙏💪🎉😎🔥🎈
#Gastro
Citations for this tweetorial 👆
19/
Rec 7 continued: The choice of weight loss or maintenance method after IGB is determined based on patient’s context and comorbidities following a shared decision-making approach. (Conditional recommendation, low certainty)
18/
Rec 7: After IGB removal, AGA suggests subsequent weight loss or maintenance interventions that include dietary interventions🍎🥗, pharmacotherapy💊, repeat IGB🎈🎈 or bariatric surgery🥼🪡.
Continued tweet👇...